Research & Education

IASLC 17th World Conference on Lung Cancer: Main Highlights

January 26, 2017 at 9:00PM EST - Recording Available



Taofeek K. Owonikoko, MD, PhD
Associate Professor
Associate Vice Chair for Faculty Development
and Translational Research
Co-Director Thoracic Oncology Program
Winship Cancer Institute of Emory University

Ramaswamy Govindan, MD - Program Chair
Co-Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology
Washington University School of Medicine

Name of Reviewer(s): 


Laurie Gaspar, MD –Nothing to Disclose

Name of Planner(s): 

Pia Hirsch-Nothing to Disclose      Carlos Ferreira-Nothing to Disclose

Name of Activity: 

IASLC 17th World Conference on Lung Cancer: Main Highlights

Date of Activity:



COI Resolution: Ensure a balanced discussion of alternative. Do not use trade names. Do not refer to company names or logos. Do not recommend therapies.

“All planning committee members’, reviewers, and/or faculty’s et.l. identified conflicts of interest pertaining to this activity were resolved prior to the activity.”

Speaker: Taofeek K. Owonikoko, MD, PhD

Supported/Contracted Research/Grant: Research grant from BMS and AstraZeneca

Program Chair: Ramaswamy Govindan, MD-

Speakers or Advisory Board , Honoraria and consulting with the following: BI, GSK, Celgene, Roche, Bayer, Genentech, Clovis, Helsinn Healthcare, ARAID Pharmaceuticals, Astellas; Honoraruim with the following: Baxalta, Roche

Type of Activity:

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?


If yes, please list:

In this live webinar Dr. Taofeek K. Owonikoko and Dr. Ramaswamy Govindan will discuss key abstracts, presentations, and developments reported in Vienna, Austria during the recent (December 4-7, 2016) 17th World Conference on Lung Cancer (WCLC).
The program will:

  • update scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies;
  • review advances in the multidisciplinary management of patients in relation to current standards of care;
  • identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.

After attending this program, participants will be able:

  • define on evolving standards of care in the multidisciplinary management of thoracic malignancies;
  • name of opportunities to participate in major, planned, and ongoing clinical trials in lung cancer;
  • discuss of treatment and management options in the personalized medicine and treatment paradigms.

Following the presentation, there will be ample time for discussion and a question/answer session. Attendees will be able to submit questions and comments to Dr. Owonikoko via internet chat.

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants. 

In order to receive CME credit, attendees must fill out a program evaluation.

Financial/Commercial and Conflicts of Interest Disclosures

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)


Please complete the evaluation link provided to you after the activity. The certificate of credit will be ready for you to print or save for your records.

IASLC Lung Cancer Grand Rounds webinars will continue throughout 2017. The goal is to hold one program monthly. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.

Use the Time Zone Converter